Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Questions raised over EIV vaccine role
New review looks at the efficacy of flu vaccination

A state-of-the-art review published in this month's Equine Veterinary Journal has raised questions about the role of equine flu vaccination in limiting the spread of infection and reducing the severity of clinical signs.

Lead author Dr Janet Daly, a virologist from the University of Nottingham's School of Veterinary Medicine, investigates how mathematical modelling could help us bring equine influenza (EIV) under control and protect horses more effectively.

The review, entitled "What can mathematical models bring to the control of equine influenza?", collates findings from a number of studies over the past 10 years.

Dr Daly concludes that while vaccination does reduce the occurrence and limit the severity of outbreaks, the protection given by equine flu vaccines is not as straightforward as we may have thought.

According to the review, EIV has the ability to mutate, thereby reducing the effectiveness of older vaccines. According to the review, none of the vaccines currently on sale in the UK contain the most recently recommended strains of the virus.

Although EIV is rarely fatal, it is highly contagious and can cause serious disruptions to training and competition schedules, resulting in large revenue losses in the equine industry.

Dr Daly said: "This study will help further our understanding of how to better protect horses against the effects of equine influenza.

"Mathematical modellers have to make some assumptions in developing models, but models are informed by and tested against real data. As a virologist, I find the questions about the data they need to generate their models challenge me to think differently about the disease."

Meanwhile, the BEVA is working with key parties to encourage further education and surveillance of EIV and establish revised guidelines to facilitate and reduce costs of approvals for vaccine strain updates.

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.